Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10–17 years of age: Results from a randomised, controlled, double-blind trial

HENDRIK RICHARDUS, Jan

Vaccine, 2013-12, Vol.31 (51), p.6136-6143 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível